Clinical Study of Prevalence of Antibiotic Resistance of Escherichia coli in Urinary Tract Infection in Children: A 9-year Retrospective, Single Center Experience
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: The aim of this study was to determine the prevalence of antibiotic susceptibility and resistance of Escherichia coli in urinary tract infections (UTIs) in children. Methods: We retrospectively reviewed the clinical records of 212 inpatients aged 18 years or younger with UTIs treated at the Pediatric Department of Dongguk University Gyeongju Hospital between January 2008 and December 2016. For comparison, patients were divided into three groups according to age as follows: group 1, ≤1 month; group 2, >1 month to ≤12 months; and group 3, ≥13 months. The antibiotic resistance rates from January 2008 to December 2012 (study period 1) and from January 2013 to December 2016 (study period 2) were analyzed statistically by group. Results: As the patient age increased, the antibiotic resistance rate to ampicillin (P =0.013), levofloxacin (P =0.050), piperacillin/tazobactam (TZP) (P <0.001), and trimethoprim/sulfamethoxazole (P =0.002) increased. The frequency of extended spectrum beta-lactamase producing E. coli showed a significant difference from 5 cases (4.6%) in study period 1 and 16 cases (15.8%) in study period 2 (P =0.007). The antibiotic resistance rate of E. coli was compared between the two time periods and we found that the antibiotic resistance rate to cefotaxime was significantly increased from 5.4% to 16.8% (P =0.008) and that to TZP was significantly decreased from 40.5% to 7.9% (P <0.001). Conclusion: Over the past 9 years, the resistance rate to cefotaxime has increased but the resistance rate to TZP has decreased. Thus, it is important to continue to investigate the antibiotic resistance rates of bacteria in the community.
Abstract
Purpose: The aim of this study was to determine the prevalence of antibiotic susceptibility and resistance of Escherichia coli in urinary tract infections (UTIs) in children. Methods: We retrospectively reviewed the clinical records of 212 inpatients aged 18 years or younger with UTIs treated at the Pediatric Department of Dongguk University Gyeongju Hospital between January 2008 and December 2016. For comparison, patients were divided into three groups according to age as follows: group 1, ≤1 month; group 2, >1 month to ≤12 months; and group 3, ≥13 months. The antibiotic resistance rates from January 2008 to December 2012 (study period 1) and from January 2013 to December 2016 (study period 2) were analyzed statistically by group. Results: As the patient age increased, the antibiotic resistance rate to ampicillin (P =0.013), levofloxacin (P =0.050), piperacillin/tazobactam (TZP) (P <0.001), and trimethoprim/sulfamethoxazole (P =0.002) increased. The frequency of extended spectrum beta-lactamase producing E. coli showed a significant difference from 5 cases (4.6%) in study period 1 and 16 cases (15.8%) in study period 2 (P =0.007). The antibiotic resistance rate of E. coli was compared between the two time periods and we found that the antibiotic resistance rate to cefotaxime was significantly increased from 5.4% to 16.8% (P =0.008) and that to TZP was significantly decreased from 40.5% to 7.9% (P <0.001). Conclusion: Over the past 9 years, the resistance rate to cefotaxime has increased but the resistance rate to TZP has decreased. Thus, it is important to continue to investigate the antibiotic resistance rates of bacteria in the community.
참고문헌 (15)
- American Academy of Pediatrics Committee on Quality Improvement Subcommittee on Urinary Tract Infection, "Practice parameter : the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children", Pediatrics, 103, pp.843~852 (1999)
- Sefton AM, "The impact of resistance on the management of urinary tract infections", Int J Antimicrob Agents, 16, pp.489~491 (2000)
- 이수영, "소아 원외 요로감염 환아에서 분리된 E. coli에 대한cefixime을 포함한 경구 항생제의 감수성 연구", Korean Journal of Pediatrics, 49(7), pp.777~783 (2006), 대한소아과학회
- 김남희, "Extended-Spectrum β - Lactamase 생성 Escherichia coli에 의한 소아 요로감염의 위험인자", Korean Journal of Pediatrics, 47(2), pp.164~169 (2004), 대한소아과학회
- 권영대, "소아 요로 감염 원인균의 항생제 감수성 고찰(2003-2005)", Childhood Kidney Diseases, 10(2), pp.182~191 (2006), 대한소아신장학회
- Elder JS, "Nelson textbook of pediatrics", pp.2223~2228 (2007), WB Saunders Co
- Warren JW, "Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA)", Clin Infect Dis, 29, pp.745~758 (1999)
- 정희진, "Escherichea coli 요로 감염과 non-Escherichea coli 요로 감염 사이의 차이점", Korean Journal of Pediatrics, 50(5), pp.457~461 (2007), 대한소아과학회
- 이용권, "소아 요로감염증의 주요 원인균과 항생제 감수성", Korean Journal of Pediatrics, 48(7), pp.760~765 (2005), 대한소아과학회
- 고영휘, "1979년과 2001년 요로감염증의 주요 원인균과 감수성의 변화에 관한 고찰", Investigative and Clinical Urology, 44(4), pp.342~350 (2003), 대한비뇨기과학회
- Daza R, "Antibiotic susceptibility of bacterial strains isolated from patients with community acquired urinary tract infections", Int J Antimicrob Agents, 18, pp.211~215 (2001)
- Khurana S, "Extended spectrum β-lactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae", Indian J Med Res, 116, pp.145~149 (2002)
- 지혜미, "소아 요로감염에서 Escherichia coli의 빈도와 항생제 감수성에 대한 연구", Childhood Kidney Diseases, 10(1), pp.18~26 (2006), 대한소아신장학회
- 이정원, "지역사회 획득 소아 요로검염에서 Extended-Spectrum b-Lactamase 생성 Escherichia coli의 발생과 위험인자", Childhood Kidney Diseases, 8(2), pp.214~222 (2004), 대한소아신장학회
- Procop GW, "Cross-class resistance to non-β-lactam antimicrobials in extended-spectrum β-lactamase-producing Klebsiella pneumoniae", Am J Clin Pathol, 120, pp.265~267 (2003)